EHS
EHS

Dexcom beats revenue guidance, eyes iCGM G6 sales for next quarter's growth

Shortly after launching its integrated continuous glucose monitoring system, Dexcom announced a 42 percent increase in year-over-year sales during its Q2 earnings call. 
“Not only did we exceed our annual growth guidance for the second consecutive quarter but the business continues to accelerate,” Kevin Ronald Sayers, CEO of Dexcom, said during the call. “All of our key segments demonstrated strong year-over-year growth with US and [out of US] revenues up 35 percent and 78 percent, respectively.”

Source link

EHS
Back to top button